Gestational Diabetes

Metabolic Diseases
1
Pipeline Programs
10
Companies
6
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

10 companies ranked by most advanced pipeline stage

Boehringer Ingelheim
Boehringer IngelheimINGELHEIM, Germany
1 program
1
Empagliflozin 10 MGPhase 31 trial
Active Trials
NCT03215069Completed91Est. Dec 2024
Heidelberg Pharma
Heidelberg PharmaGermany - Ladenburg
1 program
Gestational DiabetesN/A1 trial
Active Trials
NCT04270578Recruiting800Est. May 2028
Jana Care
Jana CareMA - Watertown
1 program
Habits-GDM mobile appN/A1 trial
Active Trials
NCT03249896UnknownEst. May 2019
Abbott
AbbottABBOTT PARK, IL
1 program
Libre 3 continuous glucose monitoring sensorN/A1 trial
Active Trials
NCT05981547Active Not Recruiting400Est. Jun 2026
Novartis
NovartisBASEL, Switzerland
1 program
The Belgian Diabetes in Pregnancy Study: BEDIP-N StudyN/A
AstraZeneca
AstraZenecaCAMBRIDGE, United Kingdom
1 program
The Belgian Diabetes in Pregnancy Study: BEDIP-N StudyN/A
Sanofi
SanofiPARIS, France
1 program
The Belgian Diabetes in Pregnancy Study: BEDIP-N StudyN/A
Novo Nordisk
Novo NordiskBAGSVAERD DENMARK, Denmark
1 program
The Belgian Diabetes in Pregnancy Study: BEDIP-N StudyN/A
M&
Merck & Co.RAHWAY, NJ
1 program
The Belgian Diabetes in Pregnancy Study: BEDIP-N StudyN/A1 trial
Active Trials
NCT02036619Completed2,006Est. Jan 2018
Bayer
BayerLEVERKUSEN, Germany
1 program
capillary blood glucose measurementN/A1 trial
Active Trials
NCT00502359Completed2,005Est. Dec 2006

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
Boehringer IngelheimEmpagliflozin 10 MG
AbbottLibre 3 continuous glucose monitoring sensor
Jana CareHabits-GDM mobile app
Merck & Co.The Belgian Diabetes in Pregnancy Study: BEDIP-N Study
Heidelberg PharmaGestational Diabetes
Bayercapillary blood glucose measurement

Clinical Trials (6)

Total enrollment: 5,302 patients across 6 trials

NCT03215069Boehringer IngelheimEmpagliflozin 10 MG

Empagliflozin and the Preservation of Beta-cell Function in Women with Recent Gestational Diabetes

Start: Jul 2018Est. completion: Dec 202491 patients
Phase 3Completed
NCT05981547AbbottLibre 3 continuous glucose monitoring sensor

Patterns and Glycaemic Endpoints for Diagnosing Gestational Diabetes

Start: Nov 2023Est. completion: Jun 2026400 patients
N/AActive Not Recruiting
NCT03249896Jana CareHabits-GDM mobile app

Web/Smartphone-based Lifestyle Coaching Program in Pregnant Women With Gestational Diabetes

Start: Sep 2017Est. completion: May 2019
N/AUnknown
NCT02036619Merck & Co.The Belgian Diabetes in Pregnancy Study: BEDIP-N Study

The Belgian Diabetes in Pregnancy Study: BEDIP-N Study

Start: Apr 2014Est. completion: Jan 20182,006 patients
N/ACompleted
NCT04270578Heidelberg PharmaGestational Diabetes

Gestational Diabetes

Start: May 2012Est. completion: May 2028800 patients
N/ARecruiting
NCT00502359Bayercapillary blood glucose measurement

Testing Ascensia Contour Glucometer for the Measurement of Blood Glucose

Start: Apr 2005Est. completion: Dec 20062,005 patients
N/ACompleted

Related Jobs in Metabolic Diseases

Senior Medical Science Liaison - Obesity - Northern CA, Central CA, NV

Amgen
California - San Francisco, US
20h ago

(Sr) Scientist Analytical Chemistry – Mass Spectrometry (Temporary role 3 years)

Johnson & Johnson
Beerse, Antwerp, Belgium
Yesterday

Computational Chemist

Topos Bio
San Francisco Office
2d ago

Associate Director, Legal Operations & Contracts Management

Kailera Therapeutics
Massachusetts
4d ago
From $155K/yr

Senior Specialist, Quality Management Systems

Crinetics Pharmaceuticals
San Diego, CA
4d ago
$91K - $114K/yr

Director, Quality Systems, Project Management, QRM, RS

Crinetics Pharmaceuticals
US California
4d ago
$178K - $223K/yr

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
1 actively recruiting trials targeting 5,302 patients
10 companies competing in this space

Related Indications

Diabetes(737)Diabetes Mellitus, Type 2(485)Obesity(246)Type 2 Diabetes(207)Type 2 Diabetes Mellitus(190)Diabetes Mellitus(127)Diabetes Mellitus, Type 1(95)Type 1 Diabetes Mellitus(51)Type 1 Diabetes(50)Dyslipidemia(45)